PACB
Pacific Biosciences of CaliforniaNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$443.94M
P/E Ratio
—
EPS
$-1.85
Beta
2.33
52W High
$2.73
52W Low
$0.85
50-Day MA
$1.65
200-Day MA
$1.67
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
-0.17
About Pacific Biosciences of California
Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to solve genetically complex problems. The company is headquartered in Menlo Park, California.
Fundamentals
| Revenue (TTM) | $160.00M |
| Gross Profit (TTM) | $54.85M |
| EBITDA | $-169.23M |
| Operating Margin | -134.50% |
| Return on Equity | -213.50% |
| Return on Assets | -33.70% |
| Revenue/Share (TTM) | $0.53 |
| Book Value | $0.02 |
| Price-to-Book | 81.58 |
| Price-to-Sales (TTM) | 2.77 |
| EV/Revenue | 5.37 |
| EV/EBITDA | 140.79 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 13.80% |
| Shares Outstanding | $302.00M |
| Float | $293.75M |
| % Insiders | 9.33% |
| % Institutions | 59.44% |
Analyst Ratings
Consensus ($2.58 target)
4
Buy5
HoldData last updated: 4/9/2026